{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:54:41Z","timestamp":1790934881745,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004166","name":"Warszawski Uniwersytet Medyczny","doi-asserted-by":"publisher","award":["NZME\/1\/Z\/GW\/N\/23"],"award-info":[{"award-number":["NZME\/1\/Z\/GW\/N\/23"]}],"id":[{"id":"10.13039\/501100004166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Osteoblast dysfunction and altered Wnt\/\u03b2-catenin-dependent responses accompany bone-remodeling imbalance in rheumatic and degenerative joint disease. Rosavin and salidroside are constituents of\n                    <jats:italic>Rhodiola rosea<\/jats:italic>\n                    preparations used without prescription, and are always encountered together rather than separately. This exploratory in vitro study asked whether the two compounds and their combination differentially affect total \u03b2-catenin concentration and cell-covered area in human osteoblasts (HOBs).\u00a0HOBs from one commercial preparation (passage 7) were cultured in growth medium (GM) or mineralization medium (MM) and exposed to rosavin 50 \u00b5M (R50), salidroside 50 \u00b5M (Sal50) or both (R50\/Sal50). Total \u03b2-catenin was quantified by ELISA in four independently cultured, treated, harvested and lysed wells per condition at days 7, 14 and 21. Cell-covered area was estimated from 79 phase-contrast fields. Welch ANOVA with Games\u2013Howell post-hoc testing was pre-specified.\u00a0Total \u03b2-catenin differed between conditions at day 14 (Welch ANOVA\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.003, Holm-adjusted\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.009; \u03b7\u00b2 = 0.43): 8.9\u2009\u00b1\u20093.8 ng\/mL in R50 versus 28.5\u2009\u00b1\u20093.8 in Sal50, 26.5\u2009\u00b1\u200916.9 in R50\/Sal50, 23.5\u2009\u00b1\u20097.9 in MM and 27.4\u2009\u00b1\u20098.6 in GM. Sal50 versus R50 was the only contrast surviving correction (difference 19.6 ng\/mL, 95% CI 13.1\u201326.1;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.002). No difference was detected at day 7 (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.87) or day 21 (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.23). Cell-covered area differed at days 7 and 21, with R50\/Sal50 lowest and most variable (54.5\u2009\u00b1\u200923.4% versus 98.1\u2009\u00b1\u20091.8% in GM at day 7). Cell-covered area explained 12% of the variance in group-mean \u03b2-catenin (\n                    <jats:italic>r<\/jats:italic>\n                    \u2009=\u2009\u2212\u20090.35).\u00a0Rosavin alone was associated with a marked reduction in total \u03b2-catenin at day 14; its combination with salidroside was not. The two constituents therefore do not act interchangeably on human osteoblasts. These observations derive from a single experimental series and require replication before mechanistic or clinical interpretation.\n                  <\/jats:p>","DOI":"10.1007\/s00296-026-06278-y","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:05:21Z","timestamp":1786982721000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rosavin, but not its combination with salidroside, lowers total \u03b2-catenin in human osteoblast cultures: an exploratory in vitro study under mineralizing conditions"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3309-996X","authenticated-orcid":false,"given":"Piotr","family":"Wojdasiewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4905-0020","authenticated-orcid":false,"given":"Edyta","family":"Wr\u00f3bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2211-0302","authenticated-orcid":false,"given":"Maria","family":"Ma\u015bli\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6219-6422","authenticated-orcid":false,"given":"Pawe\u0142","family":"Turczyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2880-0072","authenticated-orcid":false,"given":"El\u017cbieta U.","family":"Stolarczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1510-3454","authenticated-orcid":false,"given":"Krzysztof","family":"Stolarczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4102-7360","authenticated-orcid":false,"given":"Agnieszka","family":"Mikulska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0124-060X","authenticated-orcid":false,"given":"Dariusz","family":"Szukiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"6278_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18061272","volume":"18","author":"A Corrado","year":"2017","unstructured":"Corrado A, Maruotti N, Cantatore FP (2017) Osteoblast role in rheumatic diseases. Int J Mol Sci 18:1272. https:\/\/doi.org\/10.3390\/ijms18061272","journal-title":"Int J Mol Sci"},{"key":"6278_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11914-013-0183-y","volume":"12","author":"R Baum","year":"2014","unstructured":"Baum R, Gravallese EM (2014) Impact of inflammation on the osteoblast in rheumatic diseases. Curr Osteoporos Rep 12:9\u201316. https:\/\/doi.org\/10.1007\/s11914-013-0183-y","journal-title":"Curr Osteoporos Rep"},{"key":"6278_CR3","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/ar2571","volume":"11","author":"G Schett","year":"2009","unstructured":"Schett G (2009) Osteoimmunology in rheumatic diseases. Arthritis Res Ther 11:210. https:\/\/doi.org\/10.1186\/ar2571","journal-title":"Arthritis Res Ther"},{"key":"6278_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3390\/biom11010048","volume":"11","author":"M Aur\u00e9al","year":"2020","unstructured":"Aur\u00e9al M, Machuca-Gayet I, Coury F (2020) Rheumatoid arthritis in the view of osteoimmunology. Biomolecules 11:48. https:\/\/doi.org\/10.3390\/biom11010048","journal-title":"Biomolecules"},{"key":"6278_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.962969","volume":"9","author":"R Sakthiswary","year":"2022","unstructured":"Sakthiswary R, Uma Veshaaliini R, Chin KY, Das S, Sirasanagandla SR (2022) Pathomechanisms of bone loss in rheumatoid arthritis. Front Med 9:962969. https:\/\/doi.org\/10.3389\/fmed.2022.962969","journal-title":"Front Med"},{"key":"6278_CR6","first-page":"304","volume":"18","author":"PK Panagopoulos","year":"2018","unstructured":"Panagopoulos PK, Lambrou GI (2018) Bone erosions in rheumatoid arthritis: recent developments in pathogenesis and therapeutic implications. J Musculoskelet Neuronal Interact 18:304\u2013319","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"6278_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41584-022-00793-5","volume":"18","author":"N Komatsu","year":"2022","unstructured":"Komatsu N, Takayanagi H (2022) Mechanisms of joint destruction in rheumatoid arthritis \u2014 immune cell-fibroblast-bone interactions. Nat Rev Rheumatol 18:415\u2013429. https:\/\/doi.org\/10.1038\/s41584-022-00793-5","journal-title":"Nat Rev Rheumatol"},{"key":"6278_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.31138\/mjr.33.1.115","volume":"33","author":"K Klavdianou","year":"2022","unstructured":"Klavdianou K, Liossis SN, Sakkas LI (2022) Molecular mechanisms of new bone formation in axial spondyloarthritis. Mediterr J Rheumatol 33:115\u2013123. https:\/\/doi.org\/10.31138\/mjr.33.1.115","journal-title":"Mediterr J Rheumatol"},{"key":"6278_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s43166-025-00363-z","volume":"52","author":"Y Yuliasih","year":"2025","unstructured":"Yuliasih Y, Soeroso J, Suryana BPP et al (2025) A narrative review of bone disease in spondyloarthropathy: molecular mechanisms and emerging advances. Egypt Rheumatol Rehabil 52:59. https:\/\/doi.org\/10.1186\/s43166-025-00363-z","journal-title":"Egypt Rheumatol Rehabil"},{"key":"6278_CR10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nm1538","volume":"13","author":"D Diarra","year":"2007","unstructured":"Diarra D, Stolina M, Polzer K et al (2007) Dickkopf-1 is a master regulator of joint remodeling. Nat Med 13:156\u2013163. https:\/\/doi.org\/10.1038\/nm1538","journal-title":"Nat Med"},{"key":"6278_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41413-024-00342-8","volume":"12","author":"L Hu","year":"2024","unstructured":"Hu L, Chen W, Qian A, Li YP (2024) Wnt\/\u03b2-catenin signaling components and mechanisms in bone formation, homeostasis, and disease. Bone Res 12:39. https:\/\/doi.org\/10.1038\/s41413-024-00342-8","journal-title":"Bone Res"},{"key":"6278_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nm.3074","volume":"19","author":"R Baron","year":"2013","unstructured":"Baron R, Kneissel M (2013) WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med 19:179\u2013192. https:\/\/doi.org\/10.1038\/nm.3074","journal-title":"Nat Med"},{"key":"6278_CR13","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","volume":"169","author":"R Nusse","year":"2017","unstructured":"Nusse R, Clevers H (2017) Wnt\/\u03b2-catenin signaling, disease, and emerging therapeutic modalities. Cell 169:985\u2013999. https:\/\/doi.org\/10.1016\/j.cell.2017.05.016","journal-title":"Cell"},{"key":"6278_CR14","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.3390\/ijms20225525","volume":"20","author":"K Maeda","year":"2019","unstructured":"Maeda K, Kobayashi Y, Udagawa N et al (2019) The regulation of bone metabolism and disorders by Wnt signaling. Int J Mol Sci 20:5525. https:\/\/doi.org\/10.3390\/ijms20225525","journal-title":"Int J Mol Sci"},{"key":"6278_CR15","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nrendo.2013.154","volume":"9","author":"E Canalis","year":"2013","unstructured":"Canalis E (2013) Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches. Nat Rev Endocrinol 9:575\u2013583. https:\/\/doi.org\/10.1038\/nrendo.2013.154","journal-title":"Nat Rev Endocrinol"},{"key":"6278_CR16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fcell.2018.00170","volume":"6","author":"KS Houschyar","year":"2019","unstructured":"Houschyar KS, Tapking C, Borrelli MR et al (2019) Wnt pathway in bone repair and regeneration \u2014 what do we know so far. Front Cell Dev Biol 6:170. https:\/\/doi.org\/10.3389\/fcell.2018.00170","journal-title":"Front Cell Dev Biol"},{"key":"6278_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/1759720X12466608","volume":"5","author":"JH Kim","year":"2013","unstructured":"Kim JH, Liu X, Wang J et al (2013) Wnt signaling in bone formation and its therapeutic potential for bone diseases. Ther Adv Musculoskelet Dis 5:13\u201331. https:\/\/doi.org\/10.1177\/1759720X12466608","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"6278_CR18","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2741\/4214","volume":"19","author":"Y Wang","year":"2014","unstructured":"Wang Y, Li YP, Paulson C et al (2014) Wnt and the Wnt signaling pathway in bone development and disease. Front Biosci 19:379\u2013407. https:\/\/doi.org\/10.2741\/4214","journal-title":"Front Biosci"},{"key":"6278_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11926-017-0679-z","volume":"19","author":"Y Zhou","year":"2017","unstructured":"Zhou Y, Wang T, Hamilton JL, Chen D (2017) Wnt\/\u03b2-catenin signaling in osteoarthritis and in other forms of arthritis. Curr Rheumatol Rep 19:53. https:\/\/doi.org\/10.1007\/s11926-017-0679-z","journal-title":"Curr Rheumatol Rep"},{"key":"6278_CR20","doi-asserted-by":"publisher","first-page":"954454","DOI":"10.3389\/fphys.2022.954454","volume":"13","author":"J Cheng","year":"2022","unstructured":"Cheng J, Zhang L, Zhang Y et al (2022) The Wnt signaling cascade in the pathogenesis of osteoarthritis and related promising treatment strategies. Front Physiol 13:954454. https:\/\/doi.org\/10.3389\/fphys.2022.954454","journal-title":"Front Physiol"},{"key":"6278_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12964-019-0411-x","volume":"17","author":"Y Wang","year":"2019","unstructured":"Wang Y, Fan X, Xing L, Tian F (2019) Wnt signaling: a promising target for osteoarthritis therapy. Cell Commun Signal 17:97. https:\/\/doi.org\/10.1186\/s12964-019-0411-x","journal-title":"Cell Commun Signal"},{"key":"6278_CR22","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/labinvest.2015.142","volume":"96","author":"Y Usami","year":"2016","unstructured":"Usami Y, Gunawardena AT, Iwamoto M, Enomoto-Iwamoto M (2016) Wnt signaling in cartilage development and diseases: lessons from animal studies. Lab Invest 96:186\u2013196. https:\/\/doi.org\/10.1038\/labinvest.2015.142","journal-title":"Lab Invest"},{"key":"6278_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20225552","volume":"20","author":"D Cici","year":"2019","unstructured":"Cici D, Corrado A, Rotondo C, Cantatore FP (2019) Wnt signaling and biological therapy in rheumatoid arthritis and spondyloarthritis. Int J Mol Sci 20:5552. https:\/\/doi.org\/10.3390\/ijms20225552","journal-title":"Int J Mol Sci"},{"key":"6278_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12196248","volume":"12","author":"\u0141 Ja\u015bkiewicz","year":"2023","unstructured":"Ja\u015bkiewicz \u0141, Chmielewski G, Kuna J, Stomp\u00f3r T, Krajewska-W\u0142odarczyk M (2023) The role of sclerostin in rheumatic diseases: a review. J Clin Med 12:6248. https:\/\/doi.org\/10.3390\/jcm12196248","journal-title":"J Clin Med"},{"key":"6278_CR25","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1210\/er.2012-1007","volume":"33","author":"HZ Ke","year":"2012","unstructured":"Ke HZ, Richards WG, Li X, Ominsky MS (2012) Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases. Endocr Rev 33:747\u2013783. https:\/\/doi.org\/10.1210\/er.2012-1007","journal-title":"Endocr Rev"},{"key":"6278_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70113","volume":"28","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Liu F, Pei Y, Lian F, Lin H (2024) Involvement of the Wnt\/\u03b2-catenin signalling pathway in heterotopic ossification and ossification-related diseases. J Cell Mol Med 28:e70113. https:\/\/doi.org\/10.1111\/jcmm.70113","journal-title":"J Cell Mol Med"},{"key":"6278_CR27","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.fct.2013.09.019","volume":"62","author":"JJ Chen","year":"2013","unstructured":"Chen JJ, Zhang NF, Mao GX et al (2013) Salidroside stimulates osteoblast differentiation through BMP signaling pathway. Food Chem Toxicol 62:499\u2013505. https:\/\/doi.org\/10.1016\/j.fct.2013.09.019","journal-title":"Food Chem Toxicol"},{"key":"6278_CR28","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1186\/s13018-021-02598-w","volume":"16","author":"XH Li","year":"2021","unstructured":"Li XH, Chen FL, Shen HL (2021) Salidroside promoted osteogenic differentiation of adipose-derived stromal cells through Wnt\/\u03b2-catenin signaling pathway. J Orthop Surg Res 16:456. https:\/\/doi.org\/10.1186\/s13018-021-02598-w","journal-title":"J Orthop Surg Res"},{"key":"6278_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3892\/etm.2021.10977","volume":"23","author":"X Wei","year":"2022","unstructured":"Wei X, Li J, Liu H, Niu C, Chen D (2022) Salidroside promotes the osteogenic and odontogenic differentiation of human dental pulp stem cells through the BMP signaling pathway. Exp Ther Med 23:55. https:\/\/doi.org\/10.3892\/etm.2021.10977","journal-title":"Exp Ther Med"},{"key":"6278_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/nu16152387","volume":"16","author":"P Wojdasiewicz","year":"2024","unstructured":"Wojdasiewicz P, Brodacki S, Cie\u015blicka E et al (2024) Salidroside: a promising agent in bone metabolism modulation. Nutrients 16:2387. https:\/\/doi.org\/10.3390\/nu16152387","journal-title":"Nutrients"},{"key":"6278_CR31","doi-asserted-by":"publisher","first-page":"153","DOI":"10.21037\/atm-20-4255","volume":"9","author":"W Zhang","year":"2021","unstructured":"Zhang W, Xu Y, Li X et al (2021) Rosavin suppresses osteoclastogenesis in vivo and in vitro by blocking the NF-\u03baB and MAPK pathways. Ann Transl Med 9:153. https:\/\/doi.org\/10.21037\/atm-20-4255","journal-title":"Ann Transl Med"},{"key":"6278_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25042117","volume":"25","author":"P Wojdasiewicz","year":"2024","unstructured":"Wojdasiewicz P, Turczyn P, Lach-Gruba A et al (2024) The role of rosavin in the pathophysiology of bone metabolism. Int J Mol Sci 25:2117. https:\/\/doi.org\/10.3390\/ijms25042117","journal-title":"Int J Mol Sci"},{"key":"6278_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26136075","volume":"26","author":"P Wojdasiewicz","year":"2025","unstructured":"Wojdasiewicz P, Wr\u00f3bel E, Stolarczyk K et al (2025) The effect of rosavin, a characteristic compound of Rhodiola rosea, on BMP-2 induction and osteoblast proliferation in vitro. Int J Mol Sci 26:6075. https:\/\/doi.org\/10.3390\/ijms26136075","journal-title":"Int J Mol Sci"},{"key":"6278_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-026-11980-y","volume":"53","author":"P Wojdasiewicz","year":"2026","unstructured":"Wojdasiewicz P, Wr\u00f3bel E, Stolarczyk EU et al (2026) Rosavin modulates CX3CL1 secretion and osteoblast morphology under mineralizing conditions in vitro. Mol Biol Rep 53:796. https:\/\/doi.org\/10.1007\/s11033-026-11980-y","journal-title":"Mol Biol Rep"},{"key":"6278_CR35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/scrt328","volume":"4","author":"F Langenbach","year":"2013","unstructured":"Langenbach F, Handschel J (2013) Effects of dexamethasone, ascorbic acid and \u03b2-glycerophosphate on the osteogenic differentiation of stem cells in vitro. Stem Cell Res Ther 4:117. https:\/\/doi.org\/10.1186\/scrt328","journal-title":"Stem Cell Res Ther"},{"key":"6278_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-40835-w","volume":"13","author":"OS Yevlashevskaya","year":"2023","unstructured":"Yevlashevskaya OS, Scheven BA, Walmsley AD, Shelton RM (2023) Differing responses of osteogenic cell lines to \u03b2-glycerophosphate. Sci Rep 13:14472. https:\/\/doi.org\/10.1038\/s41598-023-40835-w","journal-title":"Sci Rep"},{"key":"6278_CR37","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/s0142-9612(99)00192-1","volume":"21","author":"MJ Coelho","year":"2000","unstructured":"Coelho MJ, Fernandes MH (2000) Human bone cell cultures in biocompatibility testing. Part II: effect of ascorbic acid, \u03b2-glycerophosphate and dexamethasone on osteoblastic differentiation. Biomaterials 21:1095\u20131102. https:\/\/doi.org\/10.1016\/s0142-9612(99)00192-1","journal-title":"Biomaterials"},{"key":"6278_CR38","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9:671\u2013675. https:\/\/doi.org\/10.1038\/nmeth.2089","journal-title":"Nat Methods"},{"key":"6278_CR39","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/bit.25115","volume":"111","author":"N Jaccard","year":"2014","unstructured":"Jaccard N, Griffin LD, Keser A et al (2014) Automated method for the rapid and precise estimation of adherent cell culture characteristics from phase contrast microscopy images. Biotechnol Bioeng 111:504\u2013517. https:\/\/doi.org\/10.1002\/bit.25115","journal-title":"Biotechnol Bioeng"},{"key":"6278_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242417435","volume":"24","author":"C Sz\u00e1sz","year":"2023","unstructured":"Sz\u00e1sz C, Pap D, Szebeni B et al (2023) Optimization of Sirius red-based microplate assay to investigate collagen production in vitro. Int J Mol Sci 24:17435. https:\/\/doi.org\/10.3390\/ijms242417435","journal-title":"Int J Mol Sci"},{"key":"6278_CR41","doi-asserted-by":"publisher","first-page":"301","DOI":"10.4103\/0972-0707.136338","volume":"17","author":"J Krithikadatta","year":"2014","unstructured":"Krithikadatta J, Gopikrishna V, Datta M (2014) CRIS Guidelines (Checklist for Reporting In-vitro Studies): a concept note on the need for standardized guidelines for improving quality and transparency in reporting in-vitro studies in experimental dental research. J Conserv Dent 17:301\u2013304. https:\/\/doi.org\/10.4103\/0972-0707.136338","journal-title":"J Conserv Dent"},{"key":"6278_CR42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2103238118","volume":"118","author":"M Macleod","year":"2021","unstructured":"Macleod M, Collings AM, Graf C et al (2021) The MDAR (Materials Design Analysis Reporting) framework for transparent reporting in the life sciences. Proc Natl Acad Sci U S A 118:e2103238118. https:\/\/doi.org\/10.1073\/pnas.2103238118","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6278_CR43","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1007\/s00296-020-04708-z","volume":"40","author":"O Iaremenko","year":"2020","unstructured":"Iaremenko O, Shynkaruk I, Fedkov D, Iaremenko K, Petelytska L (2020) Bone turnover biomarkers, disease activity, and MRI changes of sacroiliac joints in patients with spondyloarthritis. Rheumatol Int 40:2057\u20132063. https:\/\/doi.org\/10.1007\/s00296-020-04708-z","journal-title":"Rheumatol Int"},{"key":"6278_CR44","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s00296-019-04298-5","volume":"39","author":"O Gercik","year":"2019","unstructured":"Gercik O, Solmaz D, Coban E et al (2019) Evaluation of serum fibroblast growth factor-23 in patients with axial spondyloarthritis and its association with sclerostin, inflammation, and spinal damage. Rheumatol Int 39:835\u2013840. https:\/\/doi.org\/10.1007\/s00296-019-04298-5","journal-title":"Rheumatol Int"},{"key":"6278_CR45","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1007\/s00296-011-1981-0","volume":"32","author":"SR Kwon","year":"2012","unstructured":"Kwon SR, Lim MJ, Suh CH et al (2012) Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy. Rheumatol Int 32:2523\u20132527. https:\/\/doi.org\/10.1007\/s00296-011-1981-0","journal-title":"Rheumatol Int"},{"key":"6278_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-024-00957-x","volume":"30","author":"X Wang","year":"2024","unstructured":"Wang X, Qu Z, Zhao S et al (2024) Wnt\/\u03b2-catenin signaling pathway: proteins\u2019 roles in osteoporosis and cancer diseases and the regulatory effects of natural compounds on osteoporosis. Mol Med 30:193. https:\/\/doi.org\/10.1186\/s10020-024-00957-x","journal-title":"Mol Med"},{"key":"6278_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41413-020-00105-1","volume":"8","author":"M Wang","year":"2020","unstructured":"Wang M, Xia F, Wei Y et al (2020) Molecular mechanisms and clinical management of cancer bone metastasis. Bone Res 8:30. https:\/\/doi.org\/10.1038\/s41413-020-00105-1","journal-title":"Bone Res"},{"key":"6278_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/cells11233934","volume":"11","author":"N Ben-Ghedalia-Peled","year":"2022","unstructured":"Ben-Ghedalia-Peled N, Vago R (2022) Wnt signaling in the development of bone metastasis. Cells 11:3934. https:\/\/doi.org\/10.3390\/cells11233934","journal-title":"Cells"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06278-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-026-06278-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06278-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:10:05Z","timestamp":1790932205000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-026-06278-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":48,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["6278"],"URL":"https:\/\/doi.org\/10.1007\/s00296-026-06278-y","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"assertion":[{"value":"7 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not involve human participants, and no biological material or personal data were collected, received or processed by the authors. It was performed exclusively on commercially purchased, permanently anonymized primary human osteoblasts (PromoCell, Heidelberg, Germany; Cat. No. C-12720); according to the supplier\u2019s documentation, the donor material was obtained with written informed consent under an ethics-approved protocol, and the authors received anonymized supplier documentation only. Under Polish law, research performed exclusively on commercially obtained, permanently anonymized human cell preparations does not constitute a medical experiment and is not subject to bioethics committee opinion; ethics approval was therefore not required and none was sought. The research was nonetheless conducted in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments, as revised by the 75th General Assembly of the World Medical Association (Helsinki, October 2024).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. The study did not involve human participants, identifiable human data or identifiable images.","order":3,"name":"Ethics","label":"Consent to participate\u00a0and consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"239"}}